丹红注射液联合培多普利片治疗糖尿病肾病的临床观察  

Clinical observation on treating diabetic nephropathy with Danhong injection plus Peiduo Puli pill

作　　者：燕树勋[1] 王颖[2] 卢新平[1] 

机构地区：[1]河南中医学院第一附属医院,河南郑州450000 [2]郑州大学第一附属医院,河南郑州450008

出　　处：《中医临床研究》2010年第18期22-23,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的：观察丹红注射液治疗早期糖尿病肾病的临床疗效。方法：早期糖尿病肾病男性患者65例，随机分成对照组和治疗组，对照组口服培多普利片，治疗组加用丹红注射液40ml静滴，共2个疗程。观察治疗前后α微球蛋白、β2微球蛋白、24h尿白蛋白排出量。结果：治疗后，治疗组α微球蛋白、β2微球蛋白、24h尿白蛋白较对照组显著降低（P〈0．05）。结论：丹红注射液能减少早期糖尿病肾病患者的尿白蛋白排泄，延缓糖尿病肾病的进展。Objective： To observe the clinical effect on treating diabetic nephropathy with Danhong injection. Methods： 65 male patients with diabetic nephropathy in earlier period were divided randomly into control group and treatment group. Control group take Peiduo Puli pill orally and treatment group inject 40ml Danhong injection for two course of treatment. To observe microglobulin α and β2, urinary albumin volume ejection in 24h prior and behind of the treatment. Results： Post-treatment, volume ejection of microglobulin αand β2, urinary albumin of treatment group are lower than control group （P〈0.05）. Conclusion： Danhong injection can reduce volume ejection of urinary albumin at early stage of diabetic nephropathy patients, and postpone advancement of diabetic nephropathy.

关 键 词：糖尿病肾病 丹红注射液 临床 

分 类 号：R587.1[医药卫生—内分泌]